Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Naproxen Sodium/Diphenhydramine in OTC Population
NCT01365052Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Aprol, diphenhydramine in Insomnia, pain, sponsored by Bayer. Started May 2011; status: completed.
02
Drugs
Aproldiphenhydramine
03
Conditions
Insomniapain
Beyond the preview
Go deeper on NCT01365052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01365052.